Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 13, 2026, 2:44 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 25–48 of 354 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Treatment Decisions Clear all

Conditions: Breast Cancer Female
Interventions: Tamoxifen, Letrozole, Anastrozole, or Exemestane; Drug
Lead sponsor: University of Virginia; Other
Eligibility: 65 Years and older · Female only
Enrollment: 354 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2034
U.S. locations: 6
States / cities: New Haven, Connecticut • Charlottesville, Virginia • Culpeper, Virginia + 3 more

Conditions: Caregiver Distress
Interventions: Stress Management and CBT, Stress Management and Metta-Meditation; Behavioral
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 18 Years to 99 Years
Enrollment: 25 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2021
U.S. locations: 1
States / cities: Denver, Colorado

Conditions: Health Care Costs, Delivery of Health Care
Interventions: Clinician Coaching Sessions, Personalized text messages to patients; Behavioral · Other
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 18 Years and older
Enrollment: 600 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Ann Arbor, Michigan

Conditions: Sleep Apnea
Interventions: Behavioral strategy program X plus Y, Behavioral strategy program X; Behavioral
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 50 Years and older
Enrollment: 128 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2027 – 2031
U.S. locations: 2
States / cities: West Los Angeles, California • Detroit, Michigan

Conditions: Breast Cancer
Interventions: Not listed
Lead sponsor: Rutgers, The State University of New Jersey; Other
Eligibility: 18 Years and older · Female only
Enrollment: 77 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2013
U.S. locations: 1
States / cities: New Brunswick, New Jersey

Conditions: Pain, Chronic Pain, Mental Disorders, Cardiovascular Diseases, Diabetes Mellitus, Type 2, Arthritis
Interventions: Unblinded to Genetic Testing Results, Blinded to Genetic Testing Results; Other
Lead sponsor: Proove Bioscience, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 100,000 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2016
U.S. locations: 31
States / cities: Beverly Hills, California • Fresno, California • La Jolla, California + 23 more

Conditions: Infectious Disease
Interventions: Not listed
Lead sponsor: Midwestern University; Other
Eligibility: 18 Years to 90 Years
Enrollment: 2,000 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2020
U.S. locations: 1
States / cities: Downers Grove, Illinois

Conditions: Sepsis, Severe Sepsis, Septic Shock
Interventions: HindSight, InSight; Other
Lead sponsor: Dascena; Industry
Eligibility: 18 Years and older
Enrollment: 37,986 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2022
U.S. locations: 3
States / cities: Springfield, Massachusetts • Camden, New Jersey • Cape May, New Jersey

Conditions: Carpal Tunnel Syndrome
Interventions: Societal cost; Other
Lead sponsor: University of Texas at Austin; Other
Eligibility: 18 Years to 89 Years
Enrollment: 184 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018
U.S. locations: 6
States / cities: Austin, Texas

Conditions: Opioid Use Disorder, Clinical Decision Support
Interventions: Refined EMBED CDS, Provider alert to order consultation with addiction counselor; Other
Lead sponsor: Yale University; Other
Eligibility: 18 Years and older
Enrollment: 379 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026
U.S. locations: 3
States / cities: Guilford, Connecticut • New Haven, Connecticut

Conditions: Melanoma
Interventions: Non-Interventional; Other
Lead sponsor: AIQ Solutions; Industry
Eligibility: 18 Years and older
Enrollment: 26 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2025
U.S. locations: 2
States / cities: Boston, Massachusetts • Madison, Wisconsin

Conditions: Teach-Back Communication, Arthritis, Knee Osteoarthritis, Knee Arthropathy
Interventions: Teach-Back Lesson; Other
Lead sponsor: Duke University; Other
Eligibility: 18 Years to 80 Years
Enrollment: 7 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2018
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Pan-cancer
Interventions: Cellworks Singula and Ventura reports; Other
Lead sponsor: Avera McKennan Hospital & University Health Center; Other
Eligibility: Not listed
Enrollment: 730 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2025
U.S. locations: 1
States / cities: Sioux Falls, South Dakota

Conditions: Adenocarcinoma of Prostate, Adenocarcinoma of the Prostate Stage I, Adenocarcinoma of the Prostate Stage II, Adenocarcinoma of the Prostate Stage III
Interventions: Personalized Treatment Recommendations, Standard patient-physician counseling interaction; Behavioral
Lead sponsor: Case Comprehensive Cancer Center; Other
Eligibility: Male only
Enrollment: 76 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2014
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Opioid Abuse (Disorder), Clinical Decision Support
Interventions: Refined EMBED CDS, Provider alert that nurse completed COWS; Other
Lead sponsor: Yale University; Other
Eligibility: 18 Years and older
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 3
States / cities: Guilford, Connecticut • New Haven, Connecticut

Conditions: Relapsing-remitting Multiple Sclerosis
Interventions: Brief Education, Motivational Interviewing-Cognitive Behavioral Therapy; Behavioral
Lead sponsor: University of Missouri, Kansas City; Other
Eligibility: 18 Years and older
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2015
U.S. locations: 2
States / cities: Kansas City, Missouri • West Orange, New Jersey

Conditions: Asthma
Interventions: CHICA Asthma Module, CHICA Control; Other
Lead sponsor: Indiana University; Other
Eligibility: 3 Years to 11 Years
Enrollment: 2,098 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2005 – 2008
U.S. locations: 1
States / cities: Indianapolis, Indiana

Conditions: Hyperbilirubinemia
Interventions: Not listed
Lead sponsor: Children's Hospitals and Clinics of Minnesota; Other
Eligibility: Up to 7 Days
Enrollment: 925 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2016
U.S. locations: 2
States / cities: Minneapolis, Minnesota • Saint Paul, Minnesota

Conditions: Alcohol Use, Suicidal Ideation/Behavior
Interventions: Self-Guided Cognitive Behavioral Therapy; Behavioral
Lead sponsor: Mark J Rzeszutek, PhD; Other
Eligibility: 18 Years and older
Enrollment: 102 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Lexington, Kentucky

Conditions: Osteo Arthritis Knee, Osteoarthritis, Hip
Interventions: OA Care Plan; Other
Lead sponsor: University of Massachusetts, Worcester; Other
Eligibility: 40 Years to 99 Years
Enrollment: 5,713 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2023
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Breast Cancer Female
Interventions: Question Prompt List; Behavioral
Lead sponsor: Georgetown University; Other
Eligibility: 40 Years to 75 Years · Female only
Enrollment: 88 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2019
U.S. locations: 2
States / cities: Washington D.C., District of Columbia • Tampa, Florida

Conditions: Stage I Squamous Cell Carcinoma of the Oropharynx, Stage II Squamous Cell Carcinoma of the Oropharynx, Stage III Squamous Cell Carcinoma of the Oropharynx, Stage IVA Squamous Cell Carcinoma of the Oropharynx, Tongue Cancer
Interventions: questionnaire administration, quality-of-life assessment; Other · Procedure
Lead sponsor: University of Chicago; Other
Eligibility: 18 Years and older
Enrollment: 37 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2015
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Breast Cancer
Interventions: Shared Decision-Making Training and Decision Aid; Behavioral
Lead sponsor: Beth Israel Deaconess Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 402 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2033
U.S. locations: 11
States / cities: Los Angeles, California • Boston, Massachusetts • Burlington, Massachusetts + 6 more

Conditions: Prostate Cancer
Interventions: Darolutamide(Nubeqa, BAY1841788); Drug
Lead sponsor: Bayer; Industry
Eligibility: 18 Years and older · Male only
Enrollment: 805 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2026
U.S. locations: 24
States / cities: Homewood, Alabama • Tucson, Arizona • San Diego, California + 21 more

Search by objective public record fields.

Pre-Operative Window of ET to Inform RT Decisions (POWER II)

Reducing Distress in Phase 1 Trial Caregivers: The P1-CaLL Study

Advancing Decisions About Virtual Service Encounters

Behavioral Optimization to Overcome Obstructive Sleep Apnea Treatment Barriers

Treatment Decision Making Between Oncologists and Women With Newly Diagnosed Breast Cancer and Their Healthy Companions

A Study of the Impact of Genetic Testing on Clinical Decision Making and Patient Care

Antibiotic Outbreak, Risk Factors for Never Event, Prediction of Inappropriate Use

Machine Learning Sepsis Alert Notification Using Clinical Data

Cost Information on Carpal Tunnel Syndrome Treatment Decisions

Adaptive Decision Support for Addiction Treatment (ADAPT) Serial Randomized Testing for Usability, Round 2

TRAQinform Assessment of Immunotherapy Response

Analyzing Challenging Clinical Discussions in Orthopaedics

A Survey of Physician and Molecular Tumor Board Perspectives on the Clinical Utility and Usability of Cellworks Singula™ and Ventura™ Reports in Facilitating Patient Treatment Decisions for Pan-Cancer Patients

Treatment Decision Analysis Model for Prostate Cancer: A Randomized Trial

Adaptive Decision Support for Addiction Treatment (ADAPT) Serial Randomized Testing for Usability, Round 3

Development of a Talk Therapy Protocol to Help Patients Make Treatment Decisions in MS

Using Computers to Assist in the Treatment of Asthma in a Pediatric Setting

Implementation of a Clinical Decision Rule for Treatment of Neonatal Jaundice in the Emergency Department

Examining the Relationship Between Ongoing Alcohol Use, Suicidal Thoughts and Behaviors and Related Constructs, and Behavioral Economic Decision-Making

Development of an Osteoarthritis (OA) Care Plan to Improve Process and Quality of OA Treatment Decisions

MEND 2: Making Treatment Decisions Using Genomic Testing

Patient Preferences in Making Treatment Decisions in Patients With Stage I-IVA Oropharyngeal Cancer

SDM POSSIBLE: A Breast Cancer Treatment Decision Aid for Women 70+ With Low-Risk Stage I Breast Cancers

A Study in Which Non-metastatic Castration-resistant Prostate Cancer (nmCRPC) Patients for Whom a Decision to Treat With Darolutamide Has Been Made Before Enrollment Are Observed and Certain Outcomes Are Described